UBE2L3 anticorps (C-Term)
-
- Antigène Voir toutes UBE2L3 Anticorps
- UBE2L3 (Ubiquitin-Conjugating Enzyme E2L 3 (UBE2L3))
-
Épitope
- AA 106-135, C-Term
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp UBE2L3 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Homologie
- B
- Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogène
- This UBE2L3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 106-135 amino acids from the C-terminal region of human UBE2L3.
- Clone
- RB41666
- Isotype
- Ig Fraction
- Top Product
- Discover our top product UBE2L3 Anticorps primaire
-
-
- Indications d'application
- WB: 1:1000. IHC-P: 1:25
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Date de péremption
- 6 months
-
-
Oral bioperformance and 21st century dissolution." dans: Molecular pharmaceutics, Vol. 7, Issue 5, pp. 1361, (2013) (PubMed).
: "Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease." dans: Human molecular genetics, Vol. 19, Issue 17, pp. 3482-8, (2010) (PubMed).
: "Multiple common variants for celiac disease influencing immune gene expression. ..." dans: Nature genetics, Vol. 42, Issue 4, pp. 295-302, (2010) (PubMed).
: "Genome-wide association study of hematological and biochemical traits in a Japanese population." dans: Nature genetics, Vol. 42, Issue 3, pp. 210-5, (2010) (PubMed).
: "Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus...." dans: Nature genetics, Vol. 41, Issue 11, pp. 1234-7, (2009) (PubMed).
: "
-
Oral bioperformance and 21st century dissolution." dans: Molecular pharmaceutics, Vol. 7, Issue 5, pp. 1361, (2013) (PubMed).
-
- Antigène
- UBE2L3 (Ubiquitin-Conjugating Enzyme E2L 3 (UBE2L3))
- Autre désignation
- UBE2L3 (UBE2L3 Produits)
- Synonymes
- anticorps E2-F1, anticorps L-UBC, anticorps UBCH7, anticorps UbcM4, anticorps C79827, anticorps Ubce7, anticorps ube2l3, anticorps wu:fc22h11, anticorps zgc:86727, anticorps UBE2L3, anticorps ube2l3l, anticorps wu:fb38h03, anticorps ubiquitin conjugating enzyme E2 L3, anticorps ubiquitin-conjugating enzyme E2L 3, anticorps ubiquitin-conjugating enzyme E2L 3a, anticorps ubiquitin conjugating enzyme E2 L3 S homeolog, anticorps ubiquitin-conjugating enzyme E2L 3b, anticorps UBE2L3, anticorps Ube2l3, anticorps ube2l3a, anticorps ube2l3.S, anticorps ube2l3b
- Sujet
- The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is demonstrated to participate in the ubiquitination of p53, c-Fos, and the NF-kB precursor p105 in vitro. Several alternatively spliced transcript variants have been found for this gene.
- Poids moléculaire
- 17862
- NCBI Accession
- NP_001243284, NP_001243285, NP_003338
- UniProt
- P68036
-